Dimethyl Sulfoxide
Back to searchMolecule Structure
Scientific Name
Dimethyl Sulfoxide
Description of the Drug
Dimethyl sulfoxide is a reversible mitogen-activated extracellular signal-regulated kinase-1 (MEK1) and MEK2 inhibitor used to treat certain types of melanoma, metastatic non-small cell lung cancer, and locally advanced or metastatic anaplastic thyroid cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01093
http://www.drugbank.ca/drugs/DB01093
Brand Name(s)
Dimethyl sulfoxide, DMSO, Domoso, Infiltrina, Rimso 50, Rimso-50, Syntexan
Company Owner(s)
Mylan Institutional Llc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
Atlas | DMSO control | dimethyl sulfoxide | DMSO | ||||
SureChEMBL | SCHEMBL59 | ||||||
PharmGKB | PA449342 | ||||||
Human Metabolome Database | HMDB0002151 | ||||||
DrugBank | DB01093 | ||||||
PubChem: Thomson Pharma | 14747335 | ||||||
PubChem | 679 | ||||||
Mcule | MCULE-2005841258 | ||||||
NMRShiftDB | 10016695 | ||||||
LINCS | LSM-36361 | ||||||
Nikkaji | J1.933J | J1.130.885F | |||||
PDBe | DMS | ||||||
BindingDB | 50026472 | ||||||
EPA CompTox Dashboard | DTXSID2021735 | ||||||
DrugCentral | 906 | ||||||
Metabolights | MTBLC28262 | ||||||
Brenda | 985 | 90295 | 207739 | 896 | 207740 | 1217 | 21960 |
Rhea | 28262 | ||||||
ChemicalBook | CB64849867 | CB7854105 | |||||
rxnorm | DIMETHYL SULFOXIDE | RIMSO-50 | |||||
KEGG Ligand | C11143 | ||||||
ChEBI | 28262 | ||||||
ZINC | ZINC000005224188 |